Literature DB >> 21912430

Stem cells: HSCT for systemic sclerosis--swallows and summers.

Alan Tyndall.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21912430     DOI： 10.1038/nrrheum.2011.136

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.

Authors:  Bridget Griffiths; Sarah Miles; Hilary Moss; Rod Robertson; Douglas Veale; Paul Emery
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

2.  Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit.

Authors:  C Bryan; C Knight; C M Black; A J Silman
Journal:  Arthritis Rheum       Date:  1999-12

3.  Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.

Authors:  F H van den Hoogen; A M Boerbooms; A J Swaak; J J Rasker; H J van Lier; L B van de Putte
Journal:  Br J Rheumatol       Date:  1996-04

4.  High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.

Authors:  Donald A Berry; Naoto T Ueno; Marcella M Johnson; Xiudong Lei; Jean Caputo; Dori A Smith; Linda J Yancey; Michael Crump; Edward A Stadtmauer; Pierre Biron; John P Crown; Peter Schmid; Jean-Pierre Lotz; Giovanni Rosti; Marco Bregni; Taner Demirer
Journal:  J Clin Oncol       Date:  2011-07-18       Impact factor: 44.544

5.  Autologous hematopoietic stem cell transplantation for autoimmune diseases.

Authors:  A Gratwohl; J Passweg; C Bocelli-Tyndall; A Fassas; J M van Laar; D Farge; M Andolina; R Arnold; E Carreras; J Finke; I Kötter; T Kozak; I Lisukov; B Löwenberg; A Marmont; J Moore; R Saccardi; J A Snowden; F van den Hoogen; N M Wulffraat; X W Zhao; A Tyndall
Journal:  Bone Marrow Transplant       Date:  2005-05       Impact factor: 5.483

6.  Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis.

Authors:  J M van Laar; D Farge; A Tyndall
Journal:  Ann Rheum Dis       Date:  2005-10       Impact factor: 19.103

7.  Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.

Authors:  Richard K Burt; Sanjiv J Shah; Karin Dill; Thomas Grant; Mihai Gheorghiade; James Schroeder; Robert Craig; Ikuo Hirano; Karin Marshall; Eric Ruderman; Borko Jovanovic; Francesca Milanetti; Sandeep Jain; Kristin Boyce; Amy Morgan; James Carr; Walter Barr
Journal:  Lancet       Date:  2011-07-21       Impact factor: 79.321

8.  The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis.

Authors:  László Czirják; Zoltán Nagy; Martin Aringer; Gabriela Riemekasten; Marco Matucci-Cerinic; Daniel E Furst
Journal:  Ann Rheum Dis       Date:  2007-01-18       Impact factor: 19.103

9.  Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Authors:  Dominique Farge; Myriam Labopin; Alan Tyndall; Athanasios Fassas; Gian Luigi Mancardi; Jaap Van Laar; Jian Ouyang; Tomas Kozak; John Moore; Ina Kötter; Virginie Chesnel; Alberto Marmont; Alois Gratwohl; Riccardo Saccardi
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

10.  Defining the intensity of conditioning regimens: working definitions.

Authors:  Andrea Bacigalupo; Karen Ballen; Doug Rizzo; Sergio Giralt; Hillard Lazarus; Vincent Ho; Jane Apperley; Shimon Slavin; Marcelo Pasquini; Brenda M Sandmaier; John Barrett; Didier Blaise; Robert Lowski; Mary Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-01       Impact factor: 5.742
  10 in total
  4 in total

Review 1.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

Review 2.  Update on stem cell transplantation for systemic sclerosis: recent trial results.

Authors:  Kamran Naraghi; Jacob M van Laar
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

Review 3.  Targeted therapies for systemic sclerosis.

Authors:  Christopher P Denton; Voon H Ong
Journal:  Nat Rev Rheumatol       Date:  2013-04-09       Impact factor: 20.543

Review 4.  Cellular Therapies in Systemic Sclerosis: Recent Progress.

Authors:  Femke C C van Rhijn-Brouwer; Hendrik Gremmels; Joost O Fledderus; Timothy R D Radstake; Marianne C Verhaar; Jacob M van Laar
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.